Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate 11014-0721
Product NDC
11014-0721- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Capsule, Extended Release
- Product Type
- Drug For Further Processing
- DEA Schedule
- Schedule CII
- Marketing Start
- April 22, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 9.375 mg/1 |
| Amphetamine Sulfate | 9.375 mg/1 |
| Dextroamphetamine Saccharate | 9.375 mg/1 |
| Dextroamphetamine Sulfate | 9.375 mg/1 |
Packaging Options(1)
1 BAG in 1 DRUM (11014-0721-1) / 83324 CAPSULE, EXTENDED RELEASE in 1 BAG